ArticleRadiation oncology (London, England)2026
Efficient clinical workflow for intraoperative electron radiation therapy with a mobile electron accelerator.
Article in Radiation oncology (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeIntraoperative radiotherapy (IORT) is designed to deliver a precise dose of ionizing radiation to a tumor or tumor bed after surgical resection. The IORT procedure can deliver targeted radiation to the tumor with increased normal tissue sparing, hence improving the efficacy of the procedure when nearby organs at risk (OAR) can be mobilized out of the field thus maximizing the therapeutic ratio. This report presents the institutional experience of establishing the IORT program, highlighting our workflow improvement, quality assurance (QA), and dosimetric practices.
methodsThe IntraOp® Mobetron® 2000 can be used to irradiate a target using megavoltage (MV) electron beams of energies 6 MeV, 9 MeV, and 12 MeV at a high dose rate of 1000 cGy/minute. Mayo Clinic Florida (MCF) has a dedicated and well-shielded QA suite adjacent to the operating room (OR) for both treatment preparation and daily QA purposes. The Mobetron is docked over the target assembly with the help of the autodocking software. The IORT workflow in the OR is assisted by the Mobility (IntraOp Medical Corp., Sunnyvale, CA) system which ensures safe and efficient maneuvering of the Mobetron. The treatment planning and beam control using the treatment console is done from inside the shielded QA room.
resultsSince its commissioning in 2016, 138 patients have been treated with IORT using the Mobetron ® 2000, at MCF. The efficacy of IORT has been utilized in the treatment of locally advanced and recurrent sites like pancreas, rectum, retroperitoneal sarcoma and some gynecologic cases.
conclusionA well-planned housing of the Mobetron, adjacent to the OR, and its timely upgrades has resulted in an efficient and safe IORT workflow.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.